Here are the 424B prospectus supplements from Ives Ultra AI Opportunities Inc. (IVAI) in our archive over the last 12 months, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A 424B covers the supplement that carries the terms of a priced offering, so if you follow IVAI and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full IVAI filings page.
Ives Ultra AI Opportunities Inc. is offering 20,000,000 shares of common stock at $10.00 per share; the underwriters may buy up to 3,000,000 additional shares to cover over-allotments. The prospectus estimates $186 million in proceeds before offering expenses, after a $14 million sales load; offering expenses are estimated at approximately $729,129. The proposed NYSE listing under IVAI requires exchange approval before trading.
The company must successfully complete a tender offer within the first 12 months after its IPO. The offer size will equal the value of Trust Account assets, and shares will be repurchased at Redemption Value. Until completion, proceeds are held in the Trust Account and invested exclusively in money market funds; afterward, remaining proceeds are invested under the company’s strategy.
Under normal circumstances, the company intends to invest at least 80% of net assets, plus borrowings for investment purposes, in AI and AI-infrastructure companies, primarily private late-stage companies in the United States. Forward contracts and other synthetic equity agreements are excluded from the 80% test. The company has no operating history as a closed-end investment company and currently holds only cash and cash equivalents.